Monique C. de Jong

CD44 Expression Predicts Local Recurrence after Radiotherapy in Larynx Cancer

Monique C. de Jong, Jimmy Pramana, Jacqueline E. van der Wal et al. · Clinical Cancer Research · 2010 · 180 citations · Full text

Medicine, Cancer Biology, Oncology +17

Pretreatment microRNA Expression Impacting on Epithelial-to-Mesenchymal Transition Predicts Intrinsic Radiosensitivity in Head and Neck Cancer Cell Lines and Patients

Monique C. de Jong, Jelle J. ten Hoeve, Reidar Grénman et al. · Clinical Cancer Research · 2015 · 84 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Development and validation of a nomogram for prediction of survival and local control in laryngeal carcinoma patients treated with radiotherapy alone: A cohort study based on 994 patients

A.G.T.M. Egelmeer, Emmanuel Rios Velazquez, J.M.A. de Jong et al. · Radiotherapy and Oncology · 2011 · 77 citations · Full text

Medicine, Oncology, Radiation Oncology +15

Stereotactic ablative body radiotherapy (SABR) combined with immunotherapy (L19-IL2) versus standard of care in stage IV NSCLC patients, ImmunoSABR: a multicentre, randomised controlled open-label phase II trial

R. Lieverse, Evert J. Van Limbergen, Cary Oberije et al. · BMC Cancer · 2020 · 46 citations · Full text

Pharmacy, Immunology, Oncology +17

The autophagy associated gene, ULK1, promotes tolerance to chronic and acute hypoxia

Marco B.E. Schaaf, Dan Cojocari, Tom G. Keulers et al. · Radiotherapy and Oncology · 2013 · 45 citations

Life Sciences, Cell Biology, Genetics +8